
    
      The objective of this prospective, two-arm, multicenter, post-market study is to evaluate
      safety through the incidence of reported device-related adverse events (AEs) through 30 days
      following use of the Endo GIA™ Reinforced Reload with Tri-Staple™ Technology in subjects
      undergoing indicated abdominal or thoracic procedures.
    
  